News Home - LabGenius

Combining human and machine intelligence to accelerate the discovery of advanced medicines.

Combining human and machine
intelligence to accelerate the
discovery of advanced medicines.

Artboard%2B1.jpg

Press releases.

Featured

LabGenius’ Research Collaboration with Sanofi Yields Positive Results

Sep 18, 2023

LabGenius’ Research Collaboration with Sanofi Yields Positive Results

Sep 18, 2023

Sep 18, 2023

LabGenius Debuts T-cell Engager Optimisation Capability That Yields Molecules with >400-fold Tumour Killing Selectivity Versus Clinical Benchmark

May 15, 2023

LabGenius Debuts T-cell Engager Optimisation Capability That Yields Molecules with >400-fold Tumour Killing Selectivity Versus Clinical Benchmark

May 15, 2023

May 15, 2023

LabGenius Appoints Prof Hendrik-Tobias Arkenau and Prof Victor Greiff as Scientific Advisors.

Apr 4, 2023

LabGenius Appoints Prof Hendrik-Tobias Arkenau and Prof Victor Greiff as Scientific Advisors.

Apr 4, 2023

Apr 4, 2023

LabGenius Wins Government Innovation Grant To Support The Development Of ML-driven Cancer Therapies

Nov 30, 2022

LabGenius Wins Government Innovation Grant To Support The Development Of ML-driven Cancer Therapies

Nov 30, 2022

Nov 30, 2022

LabGenius Appoints Dr. Leonard Wossnig as Chief Technology Officer

Nov 16, 2022

LabGenius Appoints Dr. Leonard Wossnig as Chief Technology Officer

Nov 16, 2022

Nov 16, 2022

LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA™

Oct 7, 2022

LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA™

Oct 7, 2022

Oct 7, 2022

LabGenius appoints Dr. Gino Van Heeke as Chief Scientific Officer

Nov 30, 2021

LabGenius appoints Dr. Gino Van Heeke as Chief Scientific Officer

Nov 30, 2021

Nov 30, 2021

LabGenius 8519.jpg

Jul 15, 2021

LabGenius announces research collaboration with Ablynx, a Sanofi Company

Jul 15, 2021

Jul 15, 2021

LabGenius_2Oct_007 (1).jpg

Oct 29, 2020

LabGenius closes series A extension, led by Atomico, bringing total round to $25M

Oct 29, 2020

Oct 29, 2020

Apr 20, 2020

LabGenius appoints Dr. Edwin Moses as Chairman of its Board of Directors

Apr 20, 2020

Apr 20, 2020

Conferences and events.

Featured

CogX Presentation | Breaking Through the 'Cognition Barrier' to Discover Novel Therapeutics

Sep 28, 2023

CogX Presentation | Breaking Through the 'Cognition Barrier' to Discover Novel Therapeutics

Sep 28, 2023

Sep 28, 2023

Immuno-oncology Summit | Poster Presentation

Aug 3, 2023

Immuno-oncology Summit | Poster Presentation

Aug 3, 2023

Aug 3, 2023

Immuno-oncology Summit | Speaker Presentation

Aug 3, 2023

Immuno-oncology Summit | Speaker Presentation

Aug 3, 2023

Aug 3, 2023

The group shared their perspectives to surface the challenges being faced by TechBio companies using machine learning to accelerate drug discovery

Sep 12, 2022

The group shared their perspectives to surface the challenges being faced by TechBio companies using machine learning to accelerate drug discovery

Sep 12, 2022

Sep 12, 2022

Founder & CEO, James Field, will be discussing the opportunities and challenges faced when ‘Scaling as a Founder’ at this year's Sifted Summit

Aug 19, 2022

Founder & CEO, James Field, will be discussing the opportunities and challenges faced when ‘Scaling as a Founder’ at this year's Sifted Summit

Aug 19, 2022

Aug 19, 2022

LabGenius is attending the BIO-Europe Spring partnering conference

Mar 28, 2022

LabGenius is attending the BIO-Europe Spring partnering conference

Mar 28, 2022

Mar 28, 2022

Data Science Lead, Katya Putintseva, presented at The Antibody Engineering & Therapeutics conference

Dec 12, 2021

Data Science Lead, Katya Putintseva, presented at The Antibody Engineering & Therapeutics conference

Dec 12, 2021

Dec 12, 2021

Lab Genius 2021-190.jpg

Oct 26, 2021

LabGenius presents a scientific poster at drug discovery conference, Discovery UK

Oct 26, 2021

Oct 26, 2021

In the news.

Featured

LabGenius' CTO, Leonard Wossnig, discusses the intersection of synthetic biology, high-throughput assays, and machine learning in the quest for cancer drugs with Harry Glorikian

Jan 17, 2024

LabGenius' CTO, Leonard Wossnig, discusses the intersection of synthetic biology, high-throughput assays, and machine learning in the quest for cancer drugs with Harry Glorikian

Jan 17, 2024

Jan 17, 2024

BBC News covers LabGenius and how it harnesses AI in the search for new medicines

Nov 15, 2023

BBC News covers LabGenius and how it harnesses AI in the search for new medicines

Nov 15, 2023

Nov 15, 2023

LabGenius' CEO, James Field, discusses ML-enabled drug discovery with Patrick Short on the Genetics Podcast

Nov 9, 2023

LabGenius' CEO, James Field, discusses ML-enabled drug discovery with Patrick Short on the Genetics Podcast

Nov 9, 2023

Nov 9, 2023

PwC | The Life Sciences Future50

Oct 19, 2023

PwC | The Life Sciences Future50

Oct 19, 2023

Oct 19, 2023

The Bio Report | Leveraging Generative AI to Design Therapeutic Antibodies

Sep 28, 2023

The Bio Report | Leveraging Generative AI to Design Therapeutic Antibodies

Sep 28, 2023

Sep 28, 2023

SynBioBeta | Machine Learning Enhances Antibody Discovery: A Glimpse into LabGenius and Sanofi's Collaborative Endeavour

Sep 18, 2023

SynBioBeta | Machine Learning Enhances Antibody Discovery: A Glimpse into LabGenius and Sanofi's Collaborative Endeavour

Sep 18, 2023

Sep 18, 2023

TechCrunch | Questions Every VC Needs to Ask About Every AI Startup’s Tech Stack

Sep 18, 2023

TechCrunch | Questions Every VC Needs to Ask About Every AI Startup’s Tech Stack

Sep 18, 2023

Sep 18, 2023

WIRED Feature | AI is Building Highly Effective Antibodies That Humans Can’t Even Imagine

Aug 9, 2023

WIRED Feature | AI is Building Highly Effective Antibodies That Humans Can’t Even Imagine

Aug 9, 2023

Aug 9, 2023

LabGenius' CEO, James Field, discusses ML-enabled drug discovery as a recent guest on the Business of Biotech podcast

Jul 7, 2023

LabGenius' CEO, James Field, discusses ML-enabled drug discovery as a recent guest on the Business of Biotech podcast

Jul 7, 2023

Jul 7, 2023

LabGenius featured in the inaugural edition of the Decoding Bio Snapshot

Jul 5, 2023

LabGenius featured in the inaugural edition of the Decoding Bio Snapshot

Jul 5, 2023

Jul 5, 2023

Awards.

Featured

LabGenius recognized by Sifted as a drug discovery startup to watch

Jan 31, 2022

LabGenius recognized by Sifted as a drug discovery startup to watch

Jan 31, 2022

Jan 31, 2022

LabGenius featured on Otta's Rocket List

Jan 19, 2021

LabGenius featured on Otta's Rocket List

Jan 19, 2021

Jan 19, 2021

LabGenius recognized as a European startup to watch by Wired

Aug 19, 2019

LabGenius recognized as a European startup to watch by Wired

Aug 19, 2019

Aug 19, 2019

Blog posts.

Featured

Blog post | LabGenius' CTO, Leonard Wossnig, introduces the 5 'V's of drug discovery data in a recent blog post

Jul 28, 2023

Blog post | LabGenius' CTO, Leonard Wossnig, introduces the 5 'V's of drug discovery data in a recent blog post

Jul 28, 2023

Jul 28, 2023

Get to know LabGenius' CTO, Ex-Rahko co-founder & CEO and former VP of AI Odyssey Therapeutics, Dr Leonard Wossnig.

Mar 10, 2023

Get to know LabGenius' CTO, Ex-Rahko co-founder & CEO and former VP of AI Odyssey Therapeutics, Dr Leonard Wossnig.

Mar 10, 2023

Mar 10, 2023

Q&A with Justin Grace, Senior Data Scientist @ LabGenius

Sep 27, 2022

Q&A with Justin Grace, Senior Data Scientist @ LabGenius

Sep 27, 2022

Sep 27, 2022

Ex-Google CFO and LabGenius Investor, Patrick Pichette, shares his advice for scaling with efficiency

Jun 15, 2022

Ex-Google CFO and LabGenius Investor, Patrick Pichette, shares his advice for scaling with efficiency

Jun 15, 2022

Jun 15, 2022

Q&A with Dr. Dan Foxler, Principal Scientist @ LabGenius

Apr 4, 2022

Q&A with Dr. Dan Foxler, Principal Scientist @ LabGenius

Apr 4, 2022

Apr 4, 2022

Putting data at the heart of decision when navigating the winding road back to the office post-Covid

Aug 23, 2021

Putting data at the heart of decision when navigating the winding road back to the office post-Covid

Aug 23, 2021

Aug 23, 2021

Q&A with Monica Faronato, Senior Scientist

Nov 16, 2020

Q&A with Monica Faronato, Senior Scientist

Nov 16, 2020

Nov 16, 2020

LabGenius tops up Series A to $25M

Oct 29, 2020

LabGenius tops up Series A to $25M

Oct 29, 2020

Oct 29, 2020

Q&A with Dr. Andy Martin, Senior Scientist

Oct 19, 2020

Q&A with Dr. Andy Martin, Senior Scientist

Oct 19, 2020

Oct 19, 2020

How to build a platform to design new protein therapeutics

Jun 12, 2020

How to build a platform to design new protein therapeutics

Jun 12, 2020

Jun 12, 2020